Immunotherapy

Showing   of 3 results

UH Rainbow physician researcher co-authors study showing experimental drug eliminates 75 percent of aggressive pancreatic tumors

John J. Letterio, MD, PhD, is Director, Angie Fowler Adolescent & Young Adult Cancer Institute at UH Rainbow, and Director of Developmental Therapeutics at Case Comprehensive Cancer Center.

Jordan Winter, MD professional headshot thumbnail image

Rare Pancreatic Cancer Patients Show Strong Response to Immunotherapy

University Hospitals Seidman Cancer Center researcher on team who made the first of its kind discovery published in Oncotarget.

David Wald, MD, PhD thumbnail image

Research Team from Wesley Center for Immunotherapy at UH Seidman Cancer Center Awarded Top Scoring Abstract Award at the 2025 International Society for Cell and Gene Therapy Annual Meeting

Dr. David Wald and his colleagues selected for their abstract "Development and Clinical Validation of a Less Than One Day CAR T-cell Therapy Manufacturing Process".

Results are loading...